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Abstract – The natural transmission routes of the three feline haemotropic mycoplasmas – Mycoplasma
haemofelis,‘ Candidatus Mycoplasma haemominutum’, and ‘Candidatus Mycoplasma turicensis’ (CMt) –
are largely unknown. Since CMt has been detected in the saliva of infected cats using PCR, we hypothesised
that direct transmission via social or aggressive contact may occur. The aim of this study was to evaluate
this transmission route. CMt-positive saliva and blood samples were obtained from three prednisolone-
treated speciﬁc pathogen-free (SPF) cats that were infected intraperitoneally with CMt. Five SPF cats were
inoculated with CMt-positive saliva or blood subcutaneously to mimic cat bites, and ﬁve cats
were inoculated orally with blood or oronasally with saliva to mimic social contact. Blood samples were
monitored for CMt infection using quantitative real-time PCR and for seroconversion using a novel western
blot assay. Neither oronasal nor subcutaneous inoculation with CMt-positive saliva led to CMt infection in
the recipient cats, as determined by PCR, independent of prior prednisolone treatment. However, when
blood containing the same CMt dose was given subcutaneously, 4 of the 5 cats became PCR-positive, while
none of the 5 cats inoculated orally with up to 500 lL of CMt-positive blood became PCR-positive.
Subsequently, the latter cats were successfully subcutaneously infected with blood. All 13 CMt-exposed
cats seroconverted. In conclusion, CMt transmission by social contact seems less likely than transmission by
aggressive interaction. The latter transmission may occur if the recipient cat is exposed to blood from an
infected cat.
haemotropic mycoplasma / transmission / ‘Candidatus Mycoplasma turicensis’ / real-time TaqMan
PCR / seroconversion
1. INTRODUCTION
Three haemotropic mycoplasmas, the causa-
tiveagentsoffelineinfectiousanaemia,havebeen
described in cats: Mycoplasma haemofelis
(Mhf), ‘Candidatus Mycoplasma haemominu-
tum’ (CMhm) and ‘Candidatus Mycoplasma
turicensis’ (CMt) [6, 23, 25, 27, 36]. Recently,
a fourth species similar to ‘Candidatus
M.haematoparvum’hasbeensuggestedtoinfect
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Article published by EDP Sciencescats [29]. The pathogenic potential of the feline
haemotropicmycoplasmaisolatesstudiedtodate
varies, and immunosuppression or pre-existing
retroviral infections may potentiate the severity
of the anaemia [9, 36].
The diagnosis of feline haemotropic myco-
plasmas (a.k.a. haemoplasmas) has been limited
because microscopic detection of the agents in
blood smears is unreliable [32, 37]. Recently,
sensitive PCR assays have been introduced
and are now considered to be the gold standard
for the detection and differentiation of all feline
haemoplasma species [33, 36, 37]. Using PCR,
the worldwide distribution of feline haemotrop-
ic mycoplasma infections has been documented
[7, 20, 29, 32, 34, 41]. To date, no commercial
routine serologic assay is available, and serodi-
agnostics have depended on crude Mhf antigens
[1, 5]. Recently, an immunodominant protein
of Mycoplasma suis, a porcine haemoplasma
species, was identiﬁed as HspA1, a surface-
localised dnaK analogue [15–17].
The natural mode of feline haemoplasma
transmission remains controversial. Experimen-
tal transmission by the intraperitoneal, intrave-
nous, and oral inoculation of infected blood
has been successful [4]. However, these early
studies were performed prior to the introduction
of speciﬁc molecular assays, so it is not known
which feline haemoplasma species were stud-
ied. More recently, blood transfusions have
been reported to be a source of Mhf and CMhm
infections [8, 37]. Furthermore, blood-sucking
arthropods may be involved in the transmission
of feline haemoplasmas. While almost 2000
unfed Ixodes spp. ticks collected from vegeta-
tion in Switzerland tested PCR-negative for
feline haemoplasmas, and positive results for
CMhm and CMt were only obtained from some
Ixodes spp. and Rhipicephalus spp. ticks col-
lected directly from animals [39], CMhm
DNA has been detected in unfed Ixodes ovatus
ticks in Japan [31]. This suggests a transstadial
transmission of CMhm at least in the latter tick
species. Moreover, Mhf and CMhm DNA was
detected in cat ﬂeas (Ctenocephalides felis) col-
lected from experimentally and naturally
infected cats and in ﬂea faeces [18, 28, 39,
42, 43], but the transmission of Mhf and CMhm
via C. felis has not been proven [42, 43].
Recently, an investigation of shedding patterns
by real-time PCR led to the detection of CMt
DNA in saliva and faeces up to nine weeks after
experimental CMt infection [39]. In the same
study, however, Mhf and CMhm DNA were
not detected in the saliva and faeces of some
naturally infected cats, despite high blood hae-
motropic mycoplasma loads [39]a n dm o s t
recently CMhm but not Mhf was detected in
the saliva and salivary glands of experimentally
infected cats [2]. We thus hypothesised that
feline haemoplasmas, and particularly CMt or
CMhm, could be transmitted by direct contact
(social or aggressive) via saliva [39, 40]. Our
hypothesis is supported by the general increase
of feline haemoplasma infections, and particu-
larly Mhf, CMhm and CMt infections, in male
cats [21, 32, 37, 38]. Moreover, an early study
reported that a history of cat bite-associated
abscesses increased the relative risk of infection
with haemotropic mycoplasmas [11]; however,
the particular haemoplasma species could not
be molecularly differentiated at the time of that
study.
The aim of the present study was to address
this hypothesis and to investigate the possibility
of direct transmission of CMt between cats. To
mimic aggressive contact and cat bites, saliva or
blood samples from CMt-infected cats were
inoculated subcutaneously into recipient cats,
while social contact between cats was simulated
by oronasal and oral inoculation. All cats were
monitored following CMt exposure, and blood
samples were assessed for CMt infection using
sensitive real-time PCR and a novel western
blot assay.
2. MATERIALS AND METHODS
2.1. Cats
Thirteen speciﬁc pathogen-free (SPF) cats
(Liberty Research, Waverly, NY, USA) were included
in this study. They were kept in a conﬁned university
facility under hygienically ideal conditions. All
experiments were ofﬁcially approved by the veteri-
nary ofﬁce of the canton of Zurich (101/2007). The
cats were kept in groups in large rooms furnished
with running boards, climbing trees, ladders, ham-
mocks, elevated sleeping places, and shielding retreat
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the start of the experiment, each cat was clinically
examined, and blood and serum samples and con-
junctival, oropharyngeal, and rectal swabs were col-
lected to verify their SPF status. The cats were
found to be negative when the samples were tested
by real-time TaqMan PCR or RT-PCR, as described
[12–14, 19, 22, 24, 30, 35–37], as follows. The blood
samples were tested for CMt; Mhf; CMhm; feline
parvovirus, calicivirus, and coronavirus; Bartonella
henselae; and feline leukaemia and immunodeﬁ-
ciency virus provirus. The conjunctival swabs were
tested for feline calicivirus, feline herpesvirus-1,
and for Chlamydophila felis. The oropharyngeal
swabs were tested for feline calicivirus and feline her-
pesvirus-1, and the rectal swabs were tested for feline
coronavirus and feline parvovirus. In addition, the
serum samples tested negative for antibodies to feline
coronavirus [26]. Cats were blood-typed using a
commercial gel column technique (ID-Gel Test
Feline A+B Typing; DiaMed AG, Cressier sur Morat,
Switzerland): 11 cats were of blood type A and two
cats were of blood type B. The two latter cats were
siblings. Three castrated adult male cats (2 and 3
years of age) were infected intraperitoneally with
CMt to obtain infectious saliva and blood samples
(ampliﬁcatory cats; Cats X, Y, and Z). Ten juvenile
cats (two months of age) housed in two groups of
5 cats each (groups A and B) were used as recipient
cats for the transmission studies. Following the con-
clusion of this study, the three ampliﬁcatory cats were
adopted; the ten recipient cats continued to remain as
study cats.
2.2. Clinical examination and sample
and inocula collection
The clinical examinations were performed by
three veterinarians. The complete haemograms of
the ampliﬁcatory cats were performed prior to
prednisolone treatment and prior to CMt infection,
daily during saliva collection, and sporadically until
24 weeks p.i. for Cats X and Y and until 17 weeks
p.i. for Cat Z. Saliva swabs (Primella, Migros
Genossenschafts-Bund, Zurich, Switzerland) were
collected every day once the blood of the cats was
blood PCR-positive. To collect large volumes of
saliva (> 1 mL) for the transmission study, saliva
production was stimulated in Cats X and Y by the
subcutaneous injection of neostigmine (Valeant
Pharmaceuticals, Birsfelden, Switzerland; up to
0.05 mg/kg) 10 min prior to ketamine/midazolam
narcosis (ketamine 20 mg/kg and midazolam
0.1 mg/kg, intramuscularly; Ve ´toquinol, Ittigen,
Switzerland/Roche, Reinach, Switzerland). The
saliva samples were divided into aliquots for inocula-
tion and PCR. The samples for inoculation were kept
at room temperature and administered within 20 min
of collection; the samples for PCR were stored at
–20  C until use. EDTA-anticoagulated blood sam-
ples and serum were collected for PCR analysis,
haematology, and western blot from the ten recipient
cats prior to, and regularly after, the CMt inoculation.
Body temperature and body weight were recorded at
each sampling date.
2.3. Haematology
Haemograms were performed using a Cell-
Dyn 3500 (Abbott, Baar, Switzerland). Packed cell
volume (PCV) values between 33% and 45% (5%
and 95% quantiles, reference range of the Clinical
Laboratory, deﬁned by identical methods from 58
healthy cats) were considered to be within the normal
range; anaemia was deﬁned as a PCV value below
33%. Modiﬁed Wright-stained blood smears (AMES
Hema Tek slide stainer, Bayer, Zurich, Switzerland)
and Diff-Quick-stained (Medion Diagnostics, Dudin-
gen, Switzerland) smears were evaluated by light
microscopy for CMt.
2.4. Intraperitoneal infection
The three ampliﬁcatory cats were infected by the
intraperitoneal administration of CMt, as previously
described [4]. Cats X, Y, and Z received 9 · 10
5 cop-
ies of CMt in 0.9–1 mL of infectious, heparinised
blood that had been preserved in 20% DMSO
(Sigma-Aldrich, Buchs, Switzerland) and stored at
–80  C. The CMt used was derived from the CMt
isolate previously described in ‘‘Cat 1’’ (passage 1)
[36]. It had been passaged through an additional
SPF cat before it was administered to Cats X and
Y. Thus, it had been passaged twice prior to inocula-
tion into Cats X and Y. For Cat Z, the original isolate
had been passaged three times prior to inoculation.
All three cats were administered two doses of meth-
ylprednisolone acetate intramuscularly (10 mg/kg,
Depo-Medrol, Pﬁzer AG, Zurich, Switzerland) in
an attempt to immunocompromise the cats; Cats X
and Y were injected 16 and 9 days prior to CMt inoc-
ulation, Cat Z was injected 8 and 1 days prior to CMt
inoculation. Additionally, beginning at 14 days p.i.,
Cat Zreceivedprednisoloneorally(4 mg/kg/d,Streuli
Pharma AG, Uznach, Switzerland) for 20 days.
During the peak bacteraemia of Cats X, Y, and Z,
40 mL of blood and 2 mL of bone marrow were col-
lected. Bone marrow aspiration was performed on the
In vivo transmission of feline haemoplasma Vet. Res. (2009) 40:45
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row aspiration needles (Monoject, 16 gauge · 2’’,
Kendall, Mansﬁeld, MA, USA) under short duration
general anaesthesia and analgesia. The cats were
administered acepromazine (Arovet AG, Zollikon,
Switzerland, 0.01 mg/kg) and buprenorphine (Essex
Chemie, Switzerland, 0.01 mg/kg) intramuscularly,
followed by an intravenous injection of propofol
(Fresenius, Bad Homburg, Germany; induction
5 mg/kg; maintenance 1 mg/kg every 2 min). Subse-
quently, the three ampliﬁcatory cats were adminis-
tered antibiotic treatment with marboﬂoxacin
(Ve ´toquinol) and/or doxycycline (Gru ¨nenthal GmbH,
Mitlo ¨di, Switzerland), as indicated in Figure 1.
2.5. Oronasal and subcutaneous exposure
to CMt DNA-containing saliva
As a model for the direct transmission of CMt via
saliva, to simulate aggressive and social contact, the
saliva from the CMt-positive ampliﬁcatory cats was
inoculated oronasally or subcutaneously into the reci-
pient cats within 20 min of collection. Five recipient
cats (group A) were exposed oronasally to the saliva
(Tab. I, A I): one drop of saliva was administered to
each nostril of the cats using a syringe, and the
remaining saliva was administered orally. Each cat
received a cumulative dose of 2.1 mL saliva contain-
ing 8 · 10
2 copies of CMt over a period of 19 days;
inoculations took place on 17 of the 19 days. The
samples were administered based on the available
volume of saliva collected from the ampliﬁcatory
cats; the volume of the PCR-positive transmitted
samples ranged from 9–200 lL per recipient
cat and day. An aliquot of 100 lL saliva containing
1 · 10
2 copies of CMt was inoculated subcutane-
ously into each of the ﬁve recipient cats in group B
(Tab. I, B I). When inoculations A I and B I were
unsuccessful, the cats were administered predniso-
lone in an attempt to immunocompromise the cats
prior to and during the next CMt inoculation, as indi-
cated in Table I (A II and B II). The development of
saliva-associated abscesses necessitated the termina-
tion of prednisolone administration in group B, and
cat 7 required treatment with amoxicillin-clavulanate
(Synulox, 25 mg/kg, every 12 h for 9 days, Pﬁzer
AG).
2.6. Oral and subcutaneous exposure
to CMt-containing blood
Since the saliva inoculations, with or without
prednisolone administration, did not lead to CMt
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Figure 1. Intraperitoneal CMt infection of the three
ampliﬁcatory SPF cats, Cats X (A), Y (B), and Z (C).
KineticsofCMtbloodload(lefty-axis,blacksquares),PCV
value (right y-axis, open squares), shedding in saliva
(triangles beneath the x-axis), and serology results as
determined by western blot (WB; circles beneath the
x-axis) throughout the course of CMt infection. The blood
loadsarepresentedasthelogcopynumberofDNAtemplate
per mL of blood. PCV is presented as a percentage.
The saliva samples were analysed by real-time PCR:
PCR-positive swabs are indicated by black triangles,
negative swabs are indicated by open triangles. Western
blot-positive and -negative serum samples are indicated by
black and open circles, respectively. From day 41 to day
50 p.i., Cats X and Y were administered marboﬂoxacin at
2 mg/kg every 24 h (white boxes marked‘‘M’’). Treatment
wasthenswitchedtodoxycyclineat10 mg/kg/dfor14days
(gray boxes marked ‘‘D’’). Cat Z was administered only
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real-time PCR, by week 4–6 after the last saliva
administration, the cats in both groups A and B were
inoculated with CMt-positive blood (Tab. I,AI I Ia n d
B III). Each cat in group A was administered 63 lL
of blood containing 8 · 10
3 copies of CMt (Tab. I,
A III). The cats were offered the blood in a syringe,
and they voluntarily licked and ingested the blood; no
rejection of the blood was observed. When the cats
remained PCR-negative at week 10, they were inoc-
ulated with a larger blood volume containing 4 · 10
5
CMt copies (Tab. I, A IV). When the cats again
remained PCR-negative at week 9 following the
larger dose, they were challenged subcutaneously
with 6 · 10
3 CMt copies in 50 lL of CMt-positive
blood (Tab. I, A V) in order to conﬁrm that the cats
could be infected with CMt. Group B cats received
1 · 10
3 CMt copies in 10 lL of blood subcutane-
ously (Tab. I, B III). In cat 7, which remained
PCR-negative, the inoculation was repeated 14 weeks
after the ﬁrst subcutaneous inoculation (Tab. I,BI V ) .
2.7. TNA extraction
Total nucleic acids (TNA) were extracted from
100 lL of EDTA-anticoagulated blood and bone
marrow using the MagNa Pure LC Total Nucleic
Acid Isolation Kit I (Roche Diagnostics). The sam-
ples were stored at –20  C prior to extraction. The
TNA was eluted in 100 lL of elution buffer. Nega-
tive extraction controls consisting of 200 lL of phos-
phate buffered saline were prepared with each batch.
The saliva samples and swabs in PBS were incubated
at 40  C for 10 min before TNA extraction, as previ-
ously described [10].
2.8. Quantitative real-time PCR
All TNA samples were analysed and quantiﬁed
by real-time TaqMan PCR for the presence of CMt
DNA, as previously described [36]. Water was used
as a negative PCR control.
Table I. Experimental setup of the CMt transmission studies: groups and numbers of cats, CMt exposure,
immunosuppression protocol, inoculum (CMt-positive saliva or blood), inoculation route, and monitoring
period.
Group
of cats
CMt exposure Administration
of prednisolone
Number
of cats
Inoculum
(total copies of CMt)
Inoculation
route
Monitoring
period
(weeks)
Group A I. Transmission
by saliva
5 2.1 mL saliva
(8 · 10
2 copies)
Oronasal 4
II. Transmission
by saliva,
immunosuppression
5 mg/kg/d
for 8 days;
2.5 mg/kg/d
for 29 days
5
a 6.1 mL saliva
(7 · 10
3 copies)
Oronasal 6
III. Transmission
by blood
5
a 63 lL blood
(8 · 10
3 copies)
Oral 10
IV. Transmission
by blood
5
a 500 lL blood
(4 · 10
5 copies)
Oral 9
V. Transmission
by blood
5
a 50 lL blood
(6 · 10
3 copies)
Subcutaneous 23
Group B I. Transmission
by saliva
5 100 lL saliva
(1 · 10
2 copies)
Subcutaneous 6
II. Transmission
by saliva,
immunosuppression
5 mg/kg/d
for 8 days;
2.5 mg/kg/d
for 14 days
5
b 2 · 200 lL saliva
(1 · 10
3 copies)
Subcutaneous 4
III. Transmission
by blood
5
b 10 lL blood
(1 · 10
3 copies)
Subcutaneous 30
IV. Transmission
by blood
1
b
(Cat 7)
10 lL blood
(1 · 10
3 copies)
Subcutaneous 9
a Same cats used in experiment A I (Cats 1, 2, 3, 4, 5).
b Same cats used in experiment B I (Cats 6, 7, 8, 9, 10).
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The recombinant HspA1 protein of Mhf
(FJ463263) was used as an antigen. The 899 bp frag-
ment was ligated into the pQE-30 Xa Vector (Qiagen,
Hombrechtikon, Switzerland), which was then trans-
formed into Top10 Escherichia coli cells (Invitrogen,
Basel, Switzerland). Protein production, SDS-PAGE,
and immunoblotting were performed as described
previously [15], with the following modiﬁcations:
protein expression was induced using 1 mM IPTG,
and E. coli cultures were grown in LB medium con-
taining 100 lg/mL of ampicillin. The 6xHis-tagged
protein was puriﬁed by nickel afﬁnity chromatogra-
phy (Qiagen) or chelating sepharose (GE Health care
biosciences, Uppsala, Sweden). A total of 10 lgo f
antigen was used per stripe, and the feline samples
were incubated at a dilution of 1:100. Immunoreac-
tive proteins were visualised using horseradish
peroxidase-conjugated goat anti-cat IgG (Sigma-
Aldrich) and 4-chloro-1-naphthol as substrate.
The western blot was evaluated with samples
from three SPF cats infected with Mhf (6 weeks
p.i.), CMhm (21 weeks p.i.), or CMt (8 weeks p.i.),
in addition to samples from ﬁve haemoplasma-free
SPF cats. To study seroconversion following CMt
infection, the three ampliﬁcatory and ten recipient
cats were tested prior to and at various time-points
following CMt exposure.
2.10. Statistics
StatisticalanalyseswereperformedusingtheExcel
add-in Analyse-it (Analyse-it Software, Leeds, UK)
and Graph-Pad Prism (GraphPad Software, San
Diego, CA, USA). For the correlation analyses, the
Spearman rank correlation test was used (pS). Contin-
uous variables were analysed for signiﬁcant
differences among the three groups using the
Kruskal-Wallistest(pKW)andDunnmultiplecompar-
isons post-test. The comparisons between two groups
were made using the Mann-Whitney U-Test (pMWU).
A p-value less than 0.05 was considered signiﬁcant.
3. RESULTS
3.1. Characteristics of cats infected
intraperitoneally with CMt
CMt DNA was detected in blood samples,
salivary swabs, and bone marrow collected
from all three ampliﬁcatory cats (Fig. 1). All
of the TNA extraction controls and negative
PCR controls were PCR-negative. Cats X and
Z became blood PCR-positive at the ﬁrst sam-
pling date, days 6 and 4 p.i., respectively;
Cat Y became blood PCR-positive on day 11
p.i. (Fig. 1). The peak CMt blood load reached
10
6 copies/mL, while the bone marrow load
reached 10
4 copies/mL. The cats remained
blood PCR-positive until treatment (see below).
Cats X, Y, and Z became anaemic, with a min-
imum PCVof 23%, 29%, and 21% at days 18,
19, and 11 p.i., respectively (Figs. 1A, 1B,a n d
1C). When the combined data from the three
cats were analysed, the haemoplasma load
was inversely correlated with the PCV value
(r = 0.35; pS = 0.0057), erythrocyte count
(r = 0.45; pS = 0.0003), and haemoglobin
value (r = 0.35; pS = 0.0060). A mild loss
of appetite and apathy were observed in all
three cats 2–3 weeks after infection.
3.2. CMt DNA shedding via saliva
Positive PCR results were obtained from the
salivary swabs collected from all three ampliﬁ-
catory cats during the peak bacteraemia (Fig. 1).
The CMt load in PCR-positive saliva samples
ranged from 1 · 10
2 to 6 · 10
3 copies/mL of
saliva (median: 7 · 10
2 copies/mL).
3.3. Transmission experiment: oronasal
and subcutaneous exposure to
CMt DNA-containing saliva
No evidence of CMt infection was detected
in any of the recipient cats after attempted trans-
mission of CMt via saliva, as determined by
real-time PCR. The results were independent
of prior prednisolone administration in the ten
cats (Tab. II,AIa n dAI Ia n dBIa n dBI I ) .
3.4. Transmission experiment: oral
and subcutaneous exposure
to CMt-containing blood
Neither low dose (8 · 10
3 CMt copies) nor
high dose (4 · 10
5 CMt copies) oral exposure
to CMt-positive blood led to infection of the
ﬁve recipient cats in group A (Tabs. I and II,
A III and A IV). These cats were subsequently
Vet. Res. (2009) 40:45 K. Museux et al.
Page 6 of 14 (page number not for citation purpose)T
a
b
l
e
I
I
.
O
u
t
c
o
m
e
o
f
C
M
t
t
r
a
n
s
m
i
s
s
i
o
n
s
t
u
d
i
e
s
(
b
l
o
o
d
r
e
a
l
-
t
i
m
e
P
C
R
a
n
d
s
e
r
o
l
o
g
y
r
e
s
u
l
t
s
)
i
n
t
h
e
g
r
o
u
p
s
a
n
d
e
x
p
e
r
i
m
e
n
t
s
d
e
s
c
r
i
b
e
d
i
n
T
a
b
l
e
I
.
G
r
o
u
p
/
C
M
t
e
x
p
o
s
u
r
e
C
a
t
1
C
a
t
2
C
a
t
3
C
a
t
4
C
a
t
5
P
C
R
S
e
r
o
l
o
g
y
P
C
R
S
e
r
o
l
o
g
y
P
C
R
S
e
r
o
l
o
g
y
P
C
R
S
e
r
o
l
o
g
y
P
C
R
S
e
r
o
l
o
g
y
A
I
.










A
I
I
.



+






A
I
I
I
.



+






A
I
V
.



+






A
V
.
+
+
+
+
+
+
+
+
+
+
C
a
t
6
C
a
t
7
C
a
t
8
C
a
t
9
C
a
t
1
0
P
C
R
S
e
r
o
l
o
g
y
P
C
R
S
e
r
o
l
o
g
y
P
C
R
S
e
r
o
l
o
g
y
P
C
R
S
e
r
o
l
o
g
y
P
C
R
S
e
r
o
l
o
g
y
B
I
.










B
I
I
.










B
I
I
I
.
+
+


+
+
+
+
+
+
B
I
V
.
n
t
n
t

+
n
t
n
t
n
t
n
t
n
t
n
t
n
t
:
n
o
t
t
e
s
t
e
d
.
In vivo transmission of feline haemoplasma Vet. Res. (2009) 40:45
(page number not for citation purpose) Page 7 of 14inoculated subcutaneously with CMt-positive
blood, and 14–45 days p.i. all cats in group
A became PCR-positive and developed a
peak blood CMt load of 10
3–10
5 copies/mL
(Tab. II,AV ;Figs. 2A–2E).
In group B, 4 of the 5 recipient cats subcu-
taneously inoculated with CMt-positive blood
(Tab. I, B III) became PCR-positive after an
average of 22 days (range: 19–33 days), with
a peak blood load ranging from 10
3–10
5 cop-
ies/mL (Tab. II, Figs. 2F–2K). One cat (Cat 7)
was administered antibiotic treatment for a
saliva-associated abscess 22–30 days prior to
blood inoculation and remained PCR-negative
throughout the study. Cat 7 was one of the
two cats with blood type B.
Clinical signs of infection (e.g. fever and
weight-loss) were absent in the ten recipient
cats. Anaemia was only observed in one case
(Cat 1, group A) in which the PCV dropped
from 37% to 28%, coinciding with peak CMt
load of 9 · 10
5 copies/mL (Fig. 2A). Similarly,
the peak bacteraemia in Cats 3 and 10 was
accompanied by a slight decrease (by 7%) in
the PCV (group A, Figs. 2C and 2K).
3.5. Comparison of experimental infections
A signiﬁcant difference in maximum CMt
blood load was observed between the ampliﬁ-
catory cats, the cats in group A, and the cats
in group B (pKW = 0.0436). The intraperitone-
ally infected cats showed a signiﬁcantly higher
bacterial load when compared to the subcutane-
ously exposed cats (groups AV and B III;
pMWU = 0.0091). A signiﬁcant difference was
also found in the length of time between CMt
exposure and the ﬁrst positive PCR result
between the three groups (pKW = 0.0229), and
cats infected intraperitoneally became PCR-
positive earlier after CMt exposure than cats
infected subcutaneously (pMWU = 0.0091).
Additionally, cats infected intraperitoneally dis-
played a lower minimum PCV value than cats
exposed subcutaneously (pMWU = 0.0182).
3.6. Correlation of anaemia with CMt load
When all CMt PCR-positive cats (n =1 2 )
were included in the analyses, the minimum
PCV value was signiﬁcantly negatively corre-
l a t e dw i t ht h em a x i m u mC M tb l o o dl o a d
(r = 0.84; pS = 0.0006; Fig. 3A). Moreover,
the minimum PCV was signiﬁcantly positively
correlated with the length of time between CMt
inoculation and the ﬁrst positive PCR blood
result (r = 0.80; pS = 0.0017; Fig. 3B), and
the peak CMt blood load was signiﬁcantly neg-
atively correlated with the length of time
between CMt inoculation and the ﬁrst positive
PCR result (r = 0.86; pS = 0.0003; Fig. 3C).
3.7. Antibiotic treatment
After doxycycline treatment, all three cats
(X, Y, and Z) became persistently blood PCR-
negative through the end of the study (17–24
weeks p.i.). The nine PCR-positive recipient
cats were not administered any antibiotics, but
they all became PCR-negative within 10–21
weeks p.i. and remained negative until the
end of the observation period (7–10 weeks
later).
3.8. Serology
The Mhf HspA1 fragment was recognised
by sera from cats infected with Mhf, CMhm,
or CMt, while sera from ﬁve haemoplasma-free
SPF cats did not react against this antigen
(Fig. 4A). All cats used in the CMt transmission
study were seronegative prior to CMt exposure
(Fig. 4B). After CMt challenge, all 13 cats
became seropositive based on the western blot
analysis (Fig. 4C). Weekly serum samples dem-
onstrated seroconversion in the majority of
these cats between 3 and 4 weeks p.i. (Figs. 1
and 2). Cats infected intraperitoneally with
CMt demonstrated seroconversion between 3
and 6 weeks p.i. (Fig. 1) and remained seropos-
itive until 13 to 15 weeks p.i. Thereafter, the
bands observed in the western blot decreased
in intensity and/or vanished over time. In group
A, 4 out of the 5 cats seroconverted 3 to 4
weeks after exposure A V (Fig. 2A and
2C–2E), while one cat, Cat 2 (Fig. 2B), had
already seroconverted 7 weeks after oronasal
saliva inoculation (A II). Cat 2 was 1 of the 2
cats with blood type B. In group B, the four
PCR-positive cats also seroconverted following
Vet. Res. (2009) 40:45 K. Museux et al.
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Figure 2. Results of transmission studies in ten SPF recipient cats after subcutaneous CMt exposures AV
(group A; cats 1–5; A–E) and B III (group B; cats 6–10; F–K). The kinetics of CMt blood load (left y-axis,
black squares), PCV value (right y-axis, open squares), and serology as determined by western blot (WB;
circles beneath the x-axis) throughout the course of CMt infection. The blood load is presented as the log
copy number of DNA template per mL of blood. The PCV is provided as a percentage. Western blot-
positive and -negative serum samples are indicated by black and open circles, respectively. Cat 7
(B) received a second subcutaneous inoculation of CMt (Tab. I, exposure B IV) at week 14 p.i. (day 103
p.i.), as indicated by the black arrow.
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(page number not for citation purpose) Page 9 of 14CMt exposure (Tab. II, B III) between 3 and 5
weeks p.i. (Figs. 2F, 2H, 2I,a n d2K). One cat,
Cat 7 (Fig. 2G), remained PCR-negative
throughout the study and subsequently serocon-
verted 8 weeks after a second subcutaneous
inoculation of 1 · 10
3 CMt copies (Tab. II,
B IV). All recipient cats remained seropositive
until the end of the study.
3.9. Blood smears
None of the infected cats, regardless of the
CMt blood load, showed characteristic
haemoplasma-like inclusions that could be
clearly identiﬁed by light microscopy of stained
blood smears.
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Figure 3. Correlation of anaemia and CMt load.
The minimum PCV value was negatively correlated
with the peak CMt blood load (A) and signiﬁcantly
positively correlated with the length of time
between CMt exposure and the ﬁrst positive PCR
result (B). The peak CMt load was signiﬁcantly
negatively correlated with the length of time
between CMt exposure and the ﬁrst positive PCR
result (C). The correlations were determined using
the Spearman rank correlation test (r and p values
indicated in the Figure).
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Figure 4. Western blot analyses of 16 experimen-
tally haemoplasma infected cats and ﬁve SPF cats
using a recombinant Mhf HspA1 as an antigen.
(A) Western blot analysis of animals infected with
different haemotropic Mycoplasmas (1: cat infected
with Mhf; 2: cat infected with CMhm; 3: cat
infected with CMt; 4–8: SPF cats). (B) Serum of
groups A and B and the ampliﬁcatory cats collected
prior to exposure. (C) Serum of groups A and B and
the ampliﬁcatory cats collected post-exposure
(5–11 weeks after inoculation with CMt-positive
blood). M: Marker; 1–5: group A cats; 6–10: group
B cats; 11–13: cats X, Y, and Z. Seroconversion
occurred as early as three weeks p.i.; one cat
seroconverted only at eight weeks after CMt
inoculation. The arrow indicates the speciﬁc band
(calculated size of 33.6 kDa).
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This was the ﬁrst experimental study to
investigate the direct transmission of CMt
(e.g. transmission via social or aggressive con-
tact between cats) using sensitive and speciﬁc
real-time PCR assays. None of the cats orona-
sally or orally exposed to saliva or blood from
CMt-infected cats became blood PCR-positive.
The same was true following the subcutaneous
inoculation of saliva. In contrast, subcutaneous
exposure to infectious blood resulted in
infection.
In a previous study, the shedding of CMt
DNAvia saliva was demonstrated in two exper-
imentally infected cats during the early, but not
at the late, phase of infection [39]. In the present
study, CMt DNA in saliva was found in all
three monitored cats. Although the CMt used
in the present study had been further passaged
in vivo, no differences were observed in the
course and kinetics of the infection or the shed-
ding pattern when compared to the original
study [36, 39]. CMt infection led to anaemia
in the prednisolone-treated cats. The cat that
received the highest dose of prednisolone
(Cat Z) showed the shortest incubation period,
the highest blood load, and the lowest PCV
value among the three ampliﬁcatory cats. An
inverse association between the CMt load and
the PCV value was found, as has been previ-
ously reported for two cats experimentally
infected with CMt [36].
Due to the unavailability of culture assays, it
could not be determined in vitro whether the
CMt DNA in the saliva of infected cats repre-
sented viable organisms. According to our ﬁnd-
ings, however, CMt-positive saliva did not pose
a major risk of infection to naı ¨ve cats. Nonethe-
less, one cat (Cat 2) seroconverted following
the oral inoculation of CMt-positive saliva.
Thus, in this cat, it appeared that at least CMt
antigens must have been transmitted via saliva.
Any resulting CMt replication must have been
below the detection limit of the PCR assay or
occurred in tissues other than the peripheral
blood. It is unlikely that the CMt load in the sal-
iva samples was too low to result in a positive
PCR result given that the same copy number
administered in blood was sufﬁcient to infect
cats following subcutaneous inoculation, even
without pre-existing prednisolone treatment.
CMt-positive blood was found to be infec-
tious when administered intravenously [36],
intraperitoneally, or subcutaneously (present
study). In contrast, the oral inoculation of
CMt-positive blood did not result in infection
in the present study. In a very early study, the
inoculation of 5 mL of blood from haemoplas-
ma-infected cats (determined by microscopy;
haemoplasma species not molecularly deter-
mined) resulted in infection in the recipient cats
[4]. In our opinion, however, it seems highly
unlikely that a cat would be exposed to such
a large volume of infectious blood under natural
conditions. Therefore, in the present study, we
did not exceed 500 lL of infectious blood col-
lected at the peak bacteraemia and aimed at
simulating a more natural process.
As a model for aggressive interactions, a
subcutaneous inoculation was selected. All cats
inoculated with as little as two drops (10 lL) of
CMt-positive blood became infected. Small
volumes of blood from a CMt-positive cat
could be transmitted to a recipient cat via a bite.
Moreover, this volume corresponds to the vol-
ume that has been reported to be consumed
by C. felis per day during haematophagous
activity [3]. Experimental studies of ﬂea
transmission have not yet been conclusive
[42, 43], and the role of C. felis in the transmis-
sion of haemoplasmas remains unclear.
The differences observed between the ampli-
ﬁcatory and recipient cats over the course of
CMt infection (minimum PCV, peak CMt load,
incubation period) may be attributable not only
to the attempted immunosuppression but also to
the different infection route, infection dose, and
age of the cats. It cannot be determined whether
each of these factors by itself had a signiﬁcant
i n ﬂ u e n c eo nt h ei n f e c t i o n ,b u t ,o v e r a l l ,t h e
shorter the incubation period and the higher
the CMt load, the lower the PCV value.
Eight of nine cats that became PCR-positive
after subcutaneous CMt exposure showed a
similar infection course: they became PCR-
positive within 2 to 5 weeks and seroconverted
within 5 weeks p.i. and within 2 weeks
following a positive blood-PCR result. A some-
what different course of infection was observed
In vivo transmission of feline haemoplasma Vet. Res. (2009) 40:45
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lings and the only two cats in the present study
with blood type B. One cat, Cat 2, was already
seropositive at the time of subcutaneous expo-
sure because it had seroconverted after oronasal
exposure to CMt-positive saliva (see above).
Cat 2 only became PCR-positive later in the
course of infection, following subcutaneous
exposure (day 45 p.i.), and developed a lower
peak CMt blood load (1.4 · 10
3 copies/mL)
compared to the other eight cats (median peak
load: 5.7 · 10
4 copies/mL). The second blood
type B cat, Cat 7, remained blood PCR-
negative, even after repeated CMt exposures.
This cat subsequently seroconverted after the
second CMt inoculation but was never blood
PCR-positive. While the oronasal exposure to
CMt antigens and the resulting immune
response in Cat 2 might have led to partial pro-
tection and a reduced CMt load, the antibiotic
treatment of Cat 7 three weeks before the ﬁrst
CMt blood inoculation may have inﬂuenced
the course of infection. Alternatively, the blood
type of the two cats, both blood type B, or other
genetic factors may have played a role in their
susceptibility to CMt. However, due to the
small number of subjects in the present study,
this cannot be determined. This course of
CMt infection described herein, i.e., serocon-
version in the absence of CMt in the peripheral
blood, as detected by real-time PCR, has not
been described previously.
The microscopy of blood smears to diagnose
CMt infection is not recommended, which is
consistent with earlier ﬁndings [32, 37]. We
assume that the inability to detect CMt via this
method may be due to the low CMt blood load
[37] ,w h i c hw a sf o u n dt ob es i g n i ﬁ c a n t l yl o w e r
than the Mhf blood load [37]. Even the peak
CMt blood load (10
6 copies/mL) corresponded
to only one CMt copy per 10
3 to 10
4 erythro-
cytes, a number that is undetectable by routine
light microscopy.
The serological assay described in this study,
based on an HspA1 fragment of Mhf detected
via western blot, demonstrated seroconversion
in all 13 cats exposed to CMt. Using this assay,
two seropositive but PCR-negative animals
were identiﬁed. Among the cats administered
antibiotics, the intensity of the western blot
band decreased and/or vanished over time,
while the ten untreated cats remained seroposi-
tive. The antibiotic treatment may have cleared
CMt from the blood and tissues, whereas a
sequestered CMt infection may have led to
the continuous low-level stimulation of the
humoural immune response in untreated cats.
The serological assay described in this study
may be an excellent tool to further investigate
the pathogenesis of haemoplasma infections.
In conclusion, our results indicate that social
contact, such as the sharing of food dishes or
grooming, with CMt-positive cats is unlikely
to pose a risk of infection to naı ¨ve cats. How-
ever, our hypothesis was partially conﬁrmed
as the direct transmission of CMt via aggressive
interaction (e.g. cat bite) may occur if the
recipient cat is exposed to a small volume of
infectious blood.
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